Daflon 500 + Viagra 50 for Erectile Dysfunction

What Each Drug Does

• Contains 90% diosmin + 10% hesperidin (both flavonoids)
• Primarily a vascular protectant used for chronic venous insufficiency and hemorrhoids
• Mechanisms relevant to ED:
  • Reduces venous stasis and increases venous tone
  • Anti-inflammatory and antioxidant effects
  • Protects endothelium and reduces oxidative stress
  • Hesperidin specifically has been shown (in animal studies) to activate the Nrf2 pathway, reducing ferroptosis and oxidative damage in penile cavernous tissue (PMID 39587831, 2025 animal study in Andrology)

• PDE5 inhibitor - the gold-standard oral treatment for ED
• Prevents breakdown of cGMP in corpus cavernosum smooth muscle
• Promotes smooth muscle relaxation and increased blood flow to the penis
• Works only with sexual stimulation

Does the Combination Make Sense? The Theory

1. Complementary mechanisms - Sildenafil works on the nitric oxide/cGMP pathway (downstream), while the flavonoids in Daflon address upstream endothelial dysfunction, oxidative stress, and venous leakage - mechanisms that sildenafil does not directly target.
2. Venous leakage / veno-occlusive dysfunction - Daflon improves venous tone. In men whose ED is partly driven by venous insufficiency (inability to trap blood in the corpus cavernosum), this could theoretically complement sildenafil's arterial effect.
3. Hesperidin and endothelial protection - The 2025 animal study found hesperidin "partially reversed impaired erectile function" in diabetic rats by reducing cavernous fibrosis and restoring endothelial and smooth muscle cell function. This is directly relevant to the commonest ED subtype (vasculogenic/diabetic ED).

What the Evidence Actually Shows

Drug Interaction Safety

• Daflon does not inhibit CYP3A4 or CYP2C9 (the enzymes that metabolize sildenafil) significantly
• Daflon does not affect blood pressure meaningfully, so it does not potentiate sildenafil's mild hypotensive effect
• No documented dangerous interaction between the two

Practical Takeaway

• Sildenafil alone has the strongest evidence base for ED and should be your primary treatment
• Daflon 500 has theoretical and early preclinical plausibility for vasculogenic/diabetic ED through oxidative stress reduction and venous tone improvement - but no confirmed benefit in human ED trials
• If you have concomitant chronic venous insufficiency or diabetes-driven ED, the combination might offer additive benefit, but this remains speculative
• Adding Daflon to sildenafil is unlikely to cause harm, but do not expect Daflon to rescue sildenafil non-response - that failure is usually due to severe arterial disease or inadequate stimulation, not venous or oxidative mechanisms